Rivamo AG

Rivamo AG was founded in Zurich and is building the most trusted legal cannabis ecosystem in Europe by combining the expertise of Swiss regulators, proven retail expertise, and secure technology platforms. Our Mission & Vision At Rivamo, we believe that cannabis can be a force for good – when cultivated, distributed, and consumed responsibly. Our goal is to lead the transition to legal cannabis in Europe by building trusted retail networks, fostering public health partnerships, and developing innovative technologies. We are rooted in Switzerland and enjoy cross-border trust. Our goal is to become the leading platform for compliant cannabis trade and research in Europe. Rivamo AG specializes in the distribution of high-quality cannabis products and, together with the Swiss Cannabis Research Association and renowned partner institutions such as ETH Zurich, the University of Zurich, the ZHAW, and the ARUD Center for Addiction Medicine, is committed to conducting what is currently the largest cannabis study in Switzerland. The aim of this study, approved by the Federal Office of Public Health (FOPH), is to scientifically monitor the regulated consumption of cannabis products under real-life conditions and to gain new insights into prevention, consumption behavior and health effects.